Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Implementation of the NEDS EyeCTester App

NCT: NCT04607369 · ENROLLING_BY_INVITATION

NCT IDNCT04607369
StatusENROLLING_BY_INVITATION
Start Date2019-01-09
Completion2028-12-31

Brief Summary

Group 4a and 4b was an FDA trial that showed that patients who have an Amsler grid abnormality on paper, have a similar abnormality on the app. Group 7a and 7b was an FDA trial that showed that normal patients do not have false positives on the Amsler app as well as on the Amsler paper version. Further Vision on the app is slightly better than vision on the standard Sloan near card using a formula (vision is 7/10th of a line better on the app).

Frequently Asked Questions

What is Implementation of the NEDS EyeCTester App?

Implementation of the NEDS EyeCTester App is a clinical trial registered under NCT04607369. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT04607369?

The current status of NCT04607369 (Implementation of the NEDS EyeCTester App) is: ENROLLING_BY_INVITATION.

When did Implementation of the NEDS EyeCTester App start?

Implementation of the NEDS EyeCTester App started on 2019-01-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.